§ BIOTECHNOLOGY
USD · BiotechnologySPRY
ARS PHARMACEUTICALS INC
USDSector · BiotechnologyMarket cap · $0MBeta · 1.04
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
98 increased/new, 59 decreased/exited (13F)
AC 13F Analysis
§ 04 · FUNDAMENTALS · THE BOOKS
| P/B | 10.08 | EPS (TTM) | -2.00 |
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 10.9M | 0.9% | ±0% |
| ORBIMED ADVISORS LLC | 8.3M | 1.3% | ±0% |
| Rubric Capital Management LP | 8.0M | 0.7% | +29% |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 7.5M | 0.7% | ±0% |
| Point72 | 6.0M | 0.0% | +89% |
| Aberdeen Group plc | 4.1M | 0.1% | +16% |
◇ AC INTELLIGENCE
Top institutional owners for SPRY as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER83.7% · 0 holders
OTHER10.3% · 140 holders
QUALITY / COMPOUNDER1.8% · 17 holders
DEALER / BANK1.4% · 20 holders
TACTICAL / MACRO1.3% · 3 holders
PASSIVE / INDEX1.3% · 9 holders
SYSTEMATIC / QUANT0.1% · 5 holders
INCOME / DEFENSIVE0.0% · 8 holders
GROWTH / MOMENTUM0.0% · 1 holder
ACTIVIST0.0% · 1 holder
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for SPRY in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention SPRY yet.